0001213900-17-007522.txt : 20170713 0001213900-17-007522.hdr.sgml : 20170713 20170713141729 ACCESSION NUMBER: 0001213900-17-007522 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170713 DATE AS OF CHANGE: 20170713 EFFECTIVENESS DATE: 20170713 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Inmune Bio, Inc. CENTRAL INDEX KEY: 0001711754 IRS NUMBER: 475205835 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-290643 FILM NUMBER: 17963271 BUSINESS ADDRESS: STREET 1: 1224 PROSPECT STREET STREET 2: SUITE 150 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 8589643720 MAIL ADDRESS: STREET 1: 1224 PROSPECT STREET STREET 2: SUITE 150 CITY: LA JOLLA STATE: CA ZIP: 92037 D 1 primary_doc.xml X0707 D LIVE 0001711754 Inmune Bio, Inc. 1224 PROSPECT STREET SUITE 150 LA JOLLA CA CALIFORNIA 92037 (858) 964-3720 NEVADA None None Corporation true 2015 David J. Moss 1224 Prospect Street Suite 150 La Jolla CA CALIFORNIA 92037 Executive Officer Director Chief Financial Officer Raymond J. Tesi 1224 Prospect Street Suite 150 La Jolla CA CALIFORNIA 92037 Executive Officer Director Chief Executive Officer Mark Lowdell 1224 Prospect Street Suite 150 La Jolla CA CALIFORNIA 92037 Executive Officer Director Chief Scientific Officer Terry R. Knapp 1224 Prospect Street Suite 150 La Jolla CA CALIFORNIA 92037 Director J. Kelly Ganjei 1224 Prospect Street Suite 150 La Jolla CA CALIFORNIA 92037 Director Biotechnology Decline to Disclose 06b false 2017-03-15 false true false 10000 Westpark Capital, Inc. 39914 Westpark Capital, Inc. 39914 1900 AVENUE OF THE STARS SUITE 310 LOS ANGELES CA CALIFORNIA 90067 IL ILLINOIS MN MINNESOTA NY NEW YORK OH OHIO SC SOUTH CAROLINA TN TENNESSEE TX TEXAS VA VIRGINIA false 5000000 3340000 1660000 false 29 47500 0 0 false Inmune Bio, Inc. /s/ David Moss David Moss CFO 2017-07-12